Evidence map›Paper›PMID 30429252›Full record

ArticleJournal of clinical microbiology2019

Ravikiran Vasireddy, Sruthi Vasireddy, Barbara A Brown-Elliott, Alexander L Greninger, Rebecca M Davidson, Kevin L Ard, Christine Y Turenne, Richard J Wallace

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ravikiran Vasireddy *Mycobacteria/Nocardia Research Laboratory, Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
Sruthi Vasireddy *Mycobacteria/Nocardia Research Laboratory, Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
Barbara A Brown-ElliottMycobacteria/Nocardia Research Laboratory, Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, USA Barbara.Elliott@uthct.edu.
Alexander L GreningerDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Rebecca M DavidsonCenter for Genes, Environment and Health, National Jewish Health, Denver, Colorado, USA.
Kevin L ArdDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Christine Y TurenneDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Richard J WallaceMycobacteria/Nocardia Research Laboratory, Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We characterize three respiratory isolates of the recently described species

Indexed as

PhylogenyAgedAnti-Bacterial AgentsBacterial ProteinsBronchiectasisChaperonin 60ChildCluster AnalysisCystic FibrosisDNA, BacterialDNA-Directed RNA PolymerasesDNA, RibosomalFemaleHumansLouisianaLung Diseases, FungalAnti-Bacterial AgentsBacterial ProteinsChaperonin 60DNA, BacterialDNA-Directed RNA PolymerasesDNA, Ribosomalheat-shock protein 65, MycobacteriumRNA polymerase beta subunitRNA, Ribosomal, 16Sbronchiectasiscystic fibrosisMycobacterium talmoniae

Identifiers

PMID30429252
PMCPMC6355530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.